| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Other income, net | 76 | - | - | - |
| Total other expense, net | -1,045 | -1,115 | -1,072 | -1,029 |
| Loss before income taxes | -1,877 | -3,689 | -4,123 | -4,664 |
| Income tax expense | 78 | 49 | 49 | 60 |
| Net loss | -1,955 | -3,738 | -4,172 | -4,724 |
| Net income (loss) attributable to non-controlling interest | 29 | 40 | -22 | -21 |
| Net loss attributable to stockholders | -1,984 | -3,778 | -4,150 | -4,703 |
| Basic and diluted (in dollars per share) | -0.05 | -0.09 | -0.1 | -0.14 |
| Weighted average shares outstanding - basic and diluted (in shares) | 40,748,000 | 40,729,000 | 40,729,000 | 34,644,000 |
Apyx Medical Corp (APYX)
Apyx Medical Corp (APYX)